Affichem, BloodLink and Mowoot win audience vote of European Health Catapult contest

Voting held on the first day of the EIT Health Summit

Affichem, BloodLink and Mowoot won in the Biotech, Digital Health and Medtech categories respectively in the audience voting segment of the European Health Catapult finals on 4 December, the first day of the EIT Health Summit.

These startups were among 21 innovative healthcare firms who won in earlier competitions to earn the right to compete in the finals of the European Health Catapult competition at the EIT Health Summit on 4-5 December in London.

After all the start-ups made their pitches for the audience on the first day of the Summit, these three won the most audience votes to receive the Public Awards of the European Health Catapult competition.

A professional jury was to make their decisions and award the top finalists in the competition on the last day of the Summit, 5 December.

The competitors, all promising healthcare start-ups, pitched their innovations in the European Health Catapult’s year-long programme of training and competitions. They will gain the attention of investors, and the Public Awards and Jury winners will share prizes worth a total of €135,000.

The Public Awards were announced at a gala dinner held on the first night of the EIT Health Summit.

About the Public Awards winners

Affichem: A biotech company whose mission is to design, develop and market innovative therapeutic molecules and theranostic markers for the treatment of cancer and neurodegenerative diseases.

BloodLink: Streamlines the sourcing and exchange of blood, and reduces blood shortages, by connecting all stakeholders on one online platform, which provides a safe, secure and cost efficient way for blood banks and hospitals to find and exchange blood across the nation.

Mowoot by Usmima: Reproduces the abdominal massage performed by physiotherapists to facilitate intestinal transit, the solution to chronic constipation that improves its effectiveness over time.